Market Overview:
The global Robots in Healthcare market was valued at USD 17.68 billion in 2022 and expected to grow at a CAGR of 18.6% during the forecast period.
Robots are increasingly being used in the healthcare industry to perform a wide range of tasks, from assisting in surgeries to disinfecting hospital rooms. Here's an overview of robots in healthcare:
Surgical robots: These robots are used to assist surgeons during procedures, such as laparoscopic surgeries. They provide more precision and control during the procedure, resulting in better outcomes for patients.
Telepresence robots: These robots allow doctors to virtually visit patients who are unable to physically meet with their doctors. The robot acts as a proxy for the doctor, allowing them to communicate with the patient via video conferencing.
Robotic exoskeletons: These devices can be used to help people with disabilities walk or perform other movements. They work by providing external support and assistance to the user's muscles and joints.
Robots for patient care: Robots are also being used to help patients with daily tasks such as taking medication, getting out of bed, and monitoring vital signs.
Disinfecting robots: With the rise of COVID-19, robots have been developed that can disinfect hospital rooms and other areas using UV-C light or other disinfecting technologies.
Overall, robots are increasingly being used in healthcare to improve patient outcomes, reduce the risk of infection, and make healthcare more efficient.
Report Scope
Report Attributes | Description |
Market Size in 2022 | USD 17.68 Billion |
Market Forecast in 2032 | USD 37.98 Billion |
CAGR % 2023-2031 | 18.6% |
Base Year | 2022 |
Historic Data | 2019-2021 |
Forecast Period | 2023-2031 |
Report USP | Production, Consumption, company share, company heatmap, company production capacity, growth factors and more |
Segments Covered | By Product Type, By Application, By End-user |
Regional Scope | North America, Europe, APAC, South America and Middle East and Africa |
Country Scope | U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria |
Key Companies | iRobot Corporation, SoftBank Robotics Group, Auris Surgical Robotics, Inc., AMP Robotics, Medrobotics, Intuitive Surgical, Microbot Medical, Kongsberg Maritime, Others |
Covid-19 Impact:The COVID-19 pandemic has had a significant impact on the use of robots in healthcare. Here are some of the ways in which the pandemic has affected the deployment and development of robots in healthcare:
Increased use of disinfecting robots: With the need to minimize the risk of infection, hospitals have turned to robots for disinfecting hospital rooms and other areas. UV-C light disinfecting robots have been deployed in many hospitals to reduce the risk of infection.
Telepresence robots for remote consultations: Telepresence robots have been used to allow doctors to communicate with patients remotely, reducing the risk of exposure to the virus. This has been particularly important for patients who are in quarantine or in areas with high infection rates.
Surgical robots: The use of surgical robots has increased during the pandemic due to the need for social distancing and the reduction of the number of personnel in the operating room. These robots have allowed surgeons to perform procedures with fewer people in the room, reducing the risk of infection.
Delivery robots: Hospitals have used delivery robots to transport medication, food, and other supplies to patients, reducing the need for human contact.
Development of new robots: The pandemic has accelerated the development of new robots for healthcare. For example, robots have been developed that can take vital signs remotely, reducing the need for direct contact with patients.
Overall, the COVID-19 pandemic has highlighted the importance of robots in healthcare and has accelerated their development and deployment in response to the crisis.
Market Dynamics:
Drivers:
Shortage of healthcare workers: There is a shortage of healthcare workers in many parts of the world, which has led to increased interest in using robots to fill the gap. Robots can perform tasks such as delivering medication and monitoring patients, allowing healthcare workers to focus on other tasks.
Improved patient outcomes: The use of robots in healthcare has been shown to improve patient outcomes. For example, surgical robots can perform procedures with greater precision and accuracy, resulting in better surgical outcomes and shorter recovery times.
Cost-effectiveness: While the initial cost of purchasing and deploying a robot can be high, they can be cost-effective in the long run. Robots can perform tasks 24/7 without the need for breaks or overtime pay, and they can reduce the need for additional staff.
Safety: Robots can improve safety in healthcare settings by reducing the risk of infection, reducing the risk of errors during surgery, and minimizing the risk of injury to healthcare workers.
Technological advancements: Advances in technology have made it possible to develop robots that are smaller, more precise, and more versatile. This has opened up new opportunities for using robots in healthcare, such as delivering medication to hard-to-reach areas of the body.
Overall, the use of robots in healthcare is driven by a combination of factors, including a shortage of healthcare workers, improved patient outcomes, cost-effectiveness, safety, and technological advancements.
Restraints:
High initial cost: The initial cost of purchasing and deploying a robot can be very high, making it difficult for many healthcare organizations to justify the investment.
Limited capabilities: While robots can perform many tasks, they are still limited in their capabilities compared to human healthcare workers. For example, robots may not be able to provide the same level of care and compassion as human healthcare workers.
Resistance to change: Some healthcare workers may be resistant to using robots, either because they are not familiar with the technology or because they fear that robots will replace their jobs.
Regulatory issues: There are still many regulatory issues to be worked out in the use of robots in healthcare. For example, there are concerns around liability if a robot were to malfunction during a procedure.
Integration with existing systems: Integrating robots into existing healthcare systems can be a challenge. For example, electronic medical records may not be compatible with robots, or there may be issues with integrating robots with other medical devices.
Overall, the adoption of robots in healthcare is limited by a combination of factors, including the high initial cost, limited capabilities compared to human healthcare workers, resistance to change, regulatory issues, and integration with existing systems.
Regional Analysis:
North America: The North American region, particularly the United States, has been at the forefront of using robots in healthcare. Surgical robots are widely used in the United States, and the region is also a leader in developing and deploying telepresence robots.
Europe: The European region has also been adopting robots in healthcare, with a particular focus on robotic exoskeletons for rehabilitation and assistive robots for elderly care. Germany, France, and the UK are leading the way in this region.
Asia-Pacific: The Asia-Pacific region is a growing market for robots in healthcare, with a focus on telepresence robots, surgical robots, and robots for patient care. Japan and South Korea are the leading countries in this region in terms of adopting robots in healthcare.
Middle East & Africa: The Middle East and Africa region is still in the early stages of adopting robots in healthcare, with a focus on using robots for disinfection and telepresence robots for remote consultations.
Overall, the adoption of robots in healthcare is influenced by factors such as healthcare infrastructure, funding availability, and regulatory policies. While North America and Europe are currently leading the way in the adoption of robots in healthcare, the Asia-Pacific region is expected to be the fastest-growing market for robots in healthcare in the coming years.
Competitive Landscape:
The global Robots in Healthcare market is highly competitive and fragmented with the presence of several players. These companies are constantly focusing on new product development, partnerships, collaborations, and mergers and acquisitions to maintain their market position and expand their geographical presence.
Some of the key players operating in the market are:
• iRobot Corporation
• SoftBank Robotics Group
• Auris Surgical Robotics, Inc.
• AMP Robotics
• Medrobotics
• Intuitive Surgical
• Microbot Medical
• Kongsberg Maritime
• Others
Segments
By Product Type
• Surgical Robotic Systems
• Rehabilitative Robotic Systems
• Non-invasive Radiosurgery Robots
• Hospital and Pharmacy Robotic Systems
By Application
• Laparoscopy
• Pharmacy Applications
• Orthopedic Surgery
• External Beam Radiation Therapy
• Physical Rehabilitation
• Neurosurgery
• Other
By End-user
• Hospitals
• Rehabilitation Centers
• Ambulatory Surgery Centers
• Others
By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt
Why to buy this Report?
The report provides quantitative and qualitative aspect for the market in terms of value and volume, along with supporting market trends, challenges, restraints.
The report provides an in depth analysis from both production and consumption point of view at the regional and country level. Key Factors considered within the report scope are Production capacity by countries/regions, average price, consumption ratio, revenue earned and gross margin.
The report provides competitive analysis of around 30-50 companies operated in the market, these companies are bifurcated into niche players, the leaders and major contenders.
The companies are analyzed in terms of following factors such as:
 Business Model
 Production Capacity, Revenue, Sales, Gross Margin
 Key Business Strategy
 SWOT Analysis
In terms of competitive landscape, the report provides distinctive factors that would help the end user in taking a key decision within the business:
 Company Share Analysis from 2018-2022
 Company Analysis by Revenue and Sales
 Company Production Capacity, Gross Margin
 Company Share Analysis by Application/End Use
 Company Share Analysis by Product/Specification
}})